We are live on ! Find out more
ACM

AIGH Capital Management Portfolio holdings

AUM $1.59B
1-Year Est. Return 855.46%
This Fund
S&P 500
This Quarter Est. Return
+14.38%
1 Year Est. Return
+855.46%
3 Year Est. Return
+3,007.26%
5 Year Est. Return
+4,204.76%
10 Year Est. Return
–
AUM
$328M
AUM Growth
-$148M
Cap. Flow
-$221M
Cap. Flow %
-67.45%
Top 10 Hldgs %
63.05%
Holding
69
New
17
Increased
10
Reduced
14
Closed
18

Top Buys

Rank Stock Value
1
CYBE
Cyberoptics Corp
CYBE
+$16M
2
MRAM icon
Everspin Technologies
MRAM
+$14.1M
3
SCYX icon
SCYNEXIS
SCYX
+$11M
4
MIRM icon
Mirum Pharmaceuticals
MIRM
+$5.26M
5
LTRX icon
Lantronix
LTRX
+$5.22M

Top Sells

Rank Stock Value
1
SIMO icon
Silicon Motion
SIMO
+$83.2M
2
EMKR
Emcore Corp
EMKR
+$22.7M
3
GRTX
Galera Therapeutics, Inc. Common Stock
GRTX
+$16.5M
4
ADMS
Adamas Pharmaceuticals
ADMS
+$12.7M
5
OIIM
02Micro International
OIIM
+$8.99M

Sector Composition

Rank Sector Weight
1 Technology 55.75%
2 Healthcare 28.63%
3 Industrials 1.21%
4 Consumer Staples 0.51%
5 Financials 0.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ACTG icon
51
Acacia Research
ACTG
$470M
– –
-362,906
Closed -$2.46M
AMSC icon
52
American Superconductor
AMSC
$1.59B
– –
-395,487
Closed -$5.77M
ANVS icon
53
Annovis Bio
ANVS
$80M
– –
-66,469
Closed -$2.11M
ASYS icon
54
Amtech Systems
ASYS
$272M
– –
-273,100
Closed -$3.12M
DAIO icon
55
Data I/O
DAIO
$30.6M
– –
-418,310
Closed -$2.73M
DRMA icon
56
CALL
Dermata Therapeutics
DRMA
$4.42M
– –
-73
Closed -$786K
DRMA icon
57
Dermata Therapeutics
DRMA
$4.42M
– –
-73
Closed -$786K
EVOK
58
DELISTED
Evoke Pharma
EVOK
– –
-11,814
Closed -$2.21M
IWM icon
59
PUT
iShares Russell 2000 ETF
IWM
$83B
– –
-500,000
Closed -$109M
NUWE icon
60
Nuwellis
NUWE
$543K
– –
0
– -$1.67M
ONDS icon
61
Ondas Inc
ONDS
$5.19B
– –
-207,070
Closed -$1.9M
PBYI icon
62
Puma Biotechnology
PBYI
$454M
– –
-864,427
Closed -$6.06M
CYTH
63
CALL
DELISTED
Cyclo Therapeutics, Inc. Common Stock
CYTH
– –
-350,000
Closed -$2.36M
GRTX
64
DELISTED
Galera Therapeutics, Inc. Common Stock
GRTX
– –
-2,036,495
Closed -$16.5M
PETV
65
CALL
DELISTED
PetVivo Holdings, Inc. Common Stock
PETV
– –
-100,000
Closed -$270K
PETV
66
DELISTED
PetVivo Holdings, Inc. Common Stock
PETV
– –
-50,000
Closed -$135K
ARDS
67
DELISTED
Aridis Pharmaceuticals Inc. Common Stock
ARDS
– –
-150,591
Closed -$554K
AVYA
68
CALL
DELISTED
Avaya Holdings Corp. Common Stock
AVYA
– –
-300,000
Closed -$5.94M
ADMS
69
DELISTED
Adamas Pharmaceuticals
ADMS
– –
-2,585,743
Closed -$12.7M
1 2
3

Similar funds

VNT
Vanguard National Trust Malvern, Pennsylvania $1.59B AUM
GWANC
Guardian Wealth Advisors (North Carolina) Raleigh, North Carolina $1.59B AUM 15.17% 1-Year Est. Return
NCL
Nishkama Capital LLC Dorado, Puerto Rico $1.58B AUM 123.32% 1-Year Est. Return
DG
DigitalBridge Group Boca Raton, Florida $1.58B AUM 62.54% 1-Year Est. Return
SS
Sunbelt Securities Houston, Texas $1.58B AUM 28.96% 1-Year Est. Return
LCM
Lakewood Capital Management New York $1.58B AUM 0.92% 1-Year Est. Return
LCM
Landscape Capital Management Englewood, New Jersey $1.58B AUM 26.88% 1-Year Est. Return
FDCP
Foster Dykema Cabot & Partners Waltham, Massachusetts $1.57B AUM 20.41% 1-Year Est. Return

AIGH Capital Management's Q4 2021 Portfolio in Review

As of Q4 2021, AIGH Capital Management held 69 positions worth $328M, down 31% from $476M the previous quarter. Its ten largest holdings account for 63% of the portfolio.

AIGH Capital Management withdrew a net $221M in Q4 2021, closing 18 positions and reducing 14 holdings. Its most notable exit was Galera Therapeutics, Inc. Common Stock, an estimated $16.5M position sold in full.

By sector, the portfolio is most concentrated in Technology at 56% of assets, up from 38% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, AIGH Capital Management opened a new position in Everspin Technologies worth $17.6M.

  • AIGH Capital Management's largest Q4 2021 buy was Everspin Technologies: 1,555,026 shares worth $17.6M.
  • AIGH Capital Management added most to Cyberoptics Corp in Q4 2021, an estimated $16M increase.
  • AIGH Capital Management's biggest Q4 2021 reduction was Silicon Motion, cutting an estimated $83.2M.
  • AIGH Capital Management fully exited Galera Therapeutics, Inc. Common Stock in Q4 2021, selling an estimated $16.5M.
  • AIGH Capital Management's ten largest holdings make up 63% of its $328M portfolio in Q4 2021.
  • AIGH Capital Management opened 17 new positions and closed 18 in Q4 2021.
  • AIGH Capital Management's portfolio value fell 31% quarter-over-quarter to $328M.

Based on AIGH Capital Management's 13F filing for Q4 2021, filed 10 Feb 2022.